New data are challenging a long-held assumption in Crohn’s disease care: that ileal disease is harder to treat than colonic…
Browsing: Clinical Updates
Small, targeted changes to how endoscopy patients are scheduled and processed can have outsized effects on both efficiency and patient…
Inflammatory bowel diseases (IBD), comprising Crohn’s disease and ulcerative colitis, are chronic, inflammatory, immune mediated, relapsing-remitting conditions of the gastrointestinal…
2025 marked a year of consolidation and momentum in gastroenterology, shaped less by single breakthroughs and more by how rapidly…
A new international study explores whether a simple blood test could help close a growing gap in colorectal cancer detection…
A new study in Nature Nanotechnology introduces a radically different approach to colorectal cancer immunotherapy: peptide-based nanorobots that simultaneously block…
New biomechanical evidence suggests that increased stiffness of the colon—driven by chronic inflammation and tissue scarring—may play a central role…
Earlier and more widespread adoption of advanced therapies—including biologics and small molecules—has not meaningfully altered long-term outcomes in Crohn’s disease…
An AI-enabled digital collaborative care model significantly improved symptoms in patients with irritable bowel syndrome (IBS), demonstrating how clinician-guided AI…
The American Gastroenterological Association’s 2025 clinical guidance reflects a clear shift toward risk-based, personalized, and technology-enabled GI care—aimed at helping…